Marvell (MRVL) PT Lowered to $50 at Piper Sandler
Tweet
Share
E-mailGet Alerts MRVL Hot Sheet
Price: $299.89 -3.44%
Rating Summary:
50 Buy, 11 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 9 | New: 23
Rating Summary:
50 Buy, 11 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 9 | New: 23
Join SI Premium – FREE
Piper Sandler analyst Harsh Kumar lowered the price target on Marvell (NASDAQ: MRVL) to $50.00 (from $60.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Definium Therapeutics Inc (DFTX) PT Raised to $60 at Oppenheimer
- MDA Ltd (MDA:CN) (MDALF) PT Raised to Cdn$64 at CIBC
- Definium Therapeutics Inc (DFTX) PT Raised to $52 at Leerink
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
